Sarepta Therapeutics (SRPT) PT Lowered to $187 at RBC Capital
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $20.78 +5.16%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 9 | New: 41
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 9 | New: 41
Join SI Premium – FREE
RBC Capital lowered its price target on Sarepta Therapeutics (NASDAQ: SRPT) to $187.00 (from $189.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$236 at Bernstein SocGen Group
- The Bancorp (TBBK) PT Lowered to $75 at Piper Sandler
- RBC Capital Slashes Fluence Energy Inc. (FLNC) PT to $4
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
